Acute Porphyria Drug Database

Monograph

A10BD05 - Metformin and Pioglitazone
Propably not porphyrinogenic
PNP

Rationale
This combination product contains two substances: metformin (ATC code: A10B A02) and pioglitazone (ATC code: A10B G03). Metformin is safety classified as Not porphyrinogenic (NP) while pioglitazone is safety classified as Probably not porphyrinogenic (PNP). The classification of the combination is according to the most porphyrinogenic of the two substances. For more details please refer to the monographs of the two substances.

Similar drugs
Explore alternative drugs in similar therapeutic classes A10B / A10BD or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
Netherlands
Competact · Competact 15 mg/850 mg, tabletten
Belgium
Competact · Competact 15 mg - 850 mg compr. pellic.
United Kingdom
Competact · Competact 15mg/850mg tablets · Metformin / Pioglitazone · Pioglitazone 15mg / Metformin 850mg tablets
Denmark
Competact
Norway
Competact
Poland
Competact · Glubrava
Luxembourg
COMPETACT
Iceland
Competact
Finland
Competact
Latvia
Competact
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙